When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RIGL - Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability
Rigel Pharmaceuticals Inc.
2025-04-04 15:31:25 ET
Summary
RIGL is a profitable, three-drug company, reporting a net income of $17.5M for 2024.
RIGL's three marketed drugs, Tavalisse (fostamatinib) remains the major generator of net product sales, accounting for two-thirds of Q4'24's net product sales.
Additional data from a phase 1b trial of R289 in lower-risk myelodysplastic syndromes should be reported in H2'25. Previous data do suggest the activity of the drug in that indication.